XOMA Royalty Corp reports results for the quarter ended December 31 - Earnings Summary

• XOMA Royalty Corp XOMA.OQ reported a quarterly adjusted loss of 45 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -49 cents. The mean expectation of three analysts for the quarter was for a loss of 30 cents per share. Wall Street expected results to range from -47 cents to -14 cents per share.

• Revenue rose 375.4% to $8.71 million from a year ago; analysts expected $8.75 million.

• XOMA Royalty Corp's reported EPS for the quarter was a loss of 45 cents​.

• The company reported a quarterly loss of $5.34 million.

• XOMA Royalty Corp shares had fallen by 22.2% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for XOMA Royalty Corp is $79.50

This summary was machine generated from LSEG data March 17 at 09:06 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)